Antiviral Activity of Genital Tract Secretions following Oral or Topical Tenofovir Pre-exposure Prophylaxis for HIV-1

BACKGROUND: Surrogate markers of HIV-1 pre-exposure prophylaxis (PrEP) and microbicide efficacy are needed. One potential surrogate is the antiviral activity in cervicovaginal lavage (CVL) after exposure to candidate products. We measured CVL antiviral activity in women using oral or vaginal tenofov...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Herold, Betsy C., Dezzutti, Charlene S., Richardson, Barbra A., Marrazzo, Jeanne, Mesquita, Pedro M.M., Carpenter, Colleen, Huber, Ashley, Louissaint, Nicolette, Marzinke, Mark A., Hillier, Sharon L., Hendrix, Craig W.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3981887/
https://ncbi.nlm.nih.gov/pubmed/24457633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000110
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares